Back
61
65
71
77
Day Range
$10.05
$10.31
52-Week Range
$9.95
$41.80
Volume
213,156
50D / 200D Avg
$11.25
/
$17.41
Prev Close
$10.13
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.8 | 10.4 |
| P/B | 0.7 | 1.2 |
| ROE % | 164.3 | 12.4 |
| Net Margin % | 20.3 | 5.3 |
| Rev Growth 5Y % | — | 5.5 |
| D/E | 0.2 | 0.6 |
Analyst Price Target
Hold
$14.00
+38.3%
Forward P/E
7.58
Forward EPS
$1.34
EPS Growth (est.)
+0.0%
Est. Revenue
2.13B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2028 |
$1.54
$1.31 – $1.73
|
2.23B | 2 |
| FY2027 |
$1.44
$1.23 – $1.62
|
2.31B | 1 |
| FY2026 |
$1.34
$1.27 – $1.40
|
2.13B | 5 |
No quarterly estimates available
Earnings Surprises
Last 3 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-28 | $0.36 | $0.36 | 0.0% |
| 2025-08-29 | $0.09 | $0.46 | +411.1% |
| 2025-05-30 | N/A | $0.54 | — |
Dividend History
1 yr streakYield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 08, 2025 | Dec 15, 2025 | $0.87 | 6.34% |
Key Takeaways
Earnings grew 214.16% over the past year
ROE of 164.31% indicates high profitability
Net margin of 20.28% shows strong profitability
Debt/Equity of 0.21 — conservative balance sheet
Generating 2.60B in free cash flow
P/E of 0.75 — trading at a low valuation
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)167.35%
Earnings (1Y)214.16%
FCF Growth (3Y)796.57%
Quality
Return on Equity
164.31%
ROIC67.61%
Net Margin20.28%
Op. Margin23.27%
Safety
Debt / Equity
0.21
Current Ratio2.37
Interest Coverage0.00
Valuation
P/E Ratio
0.75
Forward P/E7.58
P/B Ratio0.71
EV/EBITDA-0.81
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 167.35% | Revenue Growth (3Y) | 402.32% |
| Earnings Growth (1Y) | 214.16% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 12.41B | Net Income (TTM) | 2.52B |
| ROE | 164.31% | ROA | 38.15% |
| Gross Margin | 45.80% | Operating Margin | 23.27% |
| Net Margin | 20.28% | Free Cash Flow (TTM) | 2.60B |
| ROIC | 67.61% | FCF Growth (3Y) | 796.57% |
| Safety | |||
| Debt / Equity | 0.21 | Current Ratio | 2.37 |
| Interest Coverage | 0.00 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 1 yrs | ||
| Valuation | |||
| P/E Ratio | 0.75 | Forward P/E | 7.58 |
| P/B Ratio | 0.71 | P/S Ratio | 0.15 |
| PEG Ratio | 0.08 | Forward PEG | N/A |
| EV/EBITDA | -0.81 | Fwd EV/EBITDA | -1.43 |
| Forward P/S | 0.88 | Fwd Earnings Yield | 13.19% |
| FCF Yield | 138.12% | ||
| Market Cap | 1.88B | Enterprise Value | -2.33B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 12.41B | 4.64B | 491.65M |
| Net Income | 2.52B | 800.90M | -90.72M |
| EPS (Diluted) | 13.71 | 4.36 | -0.79 |
| Gross Profit | 5.68B | 1.97B | 133.07M |
| Operating Income | 2.89B | 1.07B | -115.84M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 6.60B | 2.94B | 393.96M |
| Total Liabilities | 3.84B | 2.53B | 701.31M |
| Shareholders' Equity | 2.65B | 408.81M | -307.42M |
| Total Debt | 548.06M | 108.84M | 63.45M |
| Cash & Equivalents | 4.75B | 2.32B | 200.75M |
| Current Assets | 5.44B | 2.65B | 275.69M |
| Current Liabilities | 2.30B | 1.45B | 297.65M |
Strategy Scores
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#207 of 1049
#96 of 826
Custom
Capital Light Compounder
#10 of 220
#46 of 619
Recent Activity
Exited
Contrarian Investing (David Dreman)
Mar 26, 2026
Exited
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Capital Light Compounder
Mar 24, 2026
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026
